TScan Therapeutics Announces Poster Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition December 16, 2021
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies December 3, 2021
Werewolf Therapeutics to Present Preclinical Data on INDUKINE™ Molecules at the 63rd American Society of Hematology (ASH) Annual Meeting December 2, 2021
